Related Experiment Video
Updated: Jun 1, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
The effect of prenatal perfluorinated chemicals exposures on pediatric atopy
I-Jen Wang1, Wu-Shiun Hsieh, Chia-Yang Chen
1Department of Pediatrics, Taipei Hospital, Department of Health, Taipei, Taiwan.
Insights
Prenatal exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) is linked to higher immunoglobulin E (IgE) levels in newborns. This association was observed specifically in male infants, suggesting a potential impact on immune development.
Area of Science:
- Environmental Health
- Immunology
- Pediatrics
Background:
- The impact of perfluorinated compounds (PFCs) on immune system development and allergic diseases remains unclear.
- Prenatal exposure to environmental chemicals is a growing concern for child health.
Purpose of the Study:
- To investigate the association between prenatal exposure to specific PFCs and immunoglobulin E (IgE) levels.
- To examine the relationship between prenatal PFC exposure and the development of atopic dermatitis (AD) in early childhood.
Main Methods:
- A cohort of newborns was assessed for cord blood PFC concentrations using Ultra-performance liquid chromatography/triple-quadrupole mass spectrometry (UPLC-MS/MS).
- Infants were followed up to age 2 years for AD development and serum total IgE levels.
- Statistical analyses explored correlations between cord blood PFCs, IgE levels, and AD incidence, with stratification by gender.
Main Results:
- Elevated levels of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in cord blood were positively correlated with cord blood IgE levels.
- This positive correlation between PFOA, PFOS, and IgE was significant in male infants.
- No significant association was found between prenatal PFOS exposure and the development of atopic dermatitis.
Conclusions:
- Prenatal exposure to PFOA and PFOS is associated with increased cord blood IgE levels, particularly in boys.
- These findings suggest a potential role for specific PFCs in modulating fetal immune system development.
Background:
The role of perfluorinated compounds (PFCs) in the immune system and allergic diseases is not well-known. This study examined the effects of pre-natal exposure to PFCs on immunoglobulin E (IgE) levels and atopic dermatitis (AD).
Methods:
In Taiwan Birth Panel cohort study, newborns with cord blood and peri-natal factors (i.e. birth body weight, weeks of gestation, and type of delivery) gathered at birth were evaluated. At the age of 2 years, information on the development of AD, environmental exposures, and serum total IgE were collected. The AD and non-AD children were compared for the concentration of cord blood serum PFCs measured by Ultra-performance liquid chromatography/triple-quadrupole mass (UPLC-MS/MS). Correlations among cord blood IgE, serum total IgE at 2 years of age, and cord blood PFC levels were made.
Results:
Of 244 children who completed the follow-up and specimen collections, 43 (17.6%) developed AD. Concentrations of cord blood serum perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluorohexane sulfonic acid (PFHxS) were median (range) 1.71 (0.75-17.40), 5.50 (0.11-48.36), 2.30 (0.38-63.87), and 0.035 (0.035-0.420)ng/mL, respectively. PFOA and PFOS levels positively correlated with cord blood IgE levels (per ln-unit: β=0.134 KU/l, p=0.047 for PFOA; β=0.161 KU/l, p=0.017 for PFOS). Analyses stratified by gender revealed that PFOA and PFOS levels positively correlated with cord blood IgE levels only in boys (per ln-unit: β=0.206 KU/l, p=0.025 for PFOA; β=0.175 KU/l, p=0.053 for PFOS). When dividing cord blood serum PFCs into quartiles in the fully adjusted models, AD had no significant association with PFOS.
Conclusions:
Pre-natal PFOA and PFOS exposures positively correlated with cord blood IgE levels.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019
Related Concept Videos
Asthma I: Introduction
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...